118th Congress Health
S. 2157: Protect Drug Innovation Act
Introduced
- Introduced (completed)
- Passed Senate (not reached)
- Passed House (not reached)
- To the President (not reached)
- Became law (not reached)
Summary
Protect Drug Innovation Act
This bill repeals several programs and requirements that were enacted under the Inflation Reduction Act of 2022 relating to the prices of prescription drugs, including (1) the Medicare Drug Price Negotiation Program, (2) provisions that require drug manufacturers to issue rebates for certain drugs under Medicare for which prices increase faster than inflation, and (3) provisions that cap annual out-of-pocket spending under the Medicare prescription drug benefit.
Written by the Congressional Research Service, Library of Congress.
Roll calls
No roll call votes have been held on this bill.
Amendments
No amendments were offered to this bill.
Cosponsors
- Marco Rubio R-FLOriginal
Who scored on this bill
No member has earned points from it yet.
See all scorers and every scoring event
Introductions and cosponsorships count toward weekly caps and show no points.
Other bills by Mike Lee
- S. 3743: To direct the Secretary of the Interior to carry out a feasibility study on a selective water withdrawal system at Glen Canyon Dam, and for other purposes
- S. 5039: License to Drill Act
- S. 3331: 2nd Lieutenant Mitch Williams Post Office (Moab, UT)
- S. 1954: Biosimilar Red Tape Elimination Act
- S. 4708: Arctic Security and Diplomacy Act
- S. 1860: Brian Head Town Land Conveyance Act
History
- Introduced in the Senate by Mike Lee.
Show the full action history (2 actions)
- Introduced in Senate
- Read twice and referred to the Committee on Finance.